Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (387)
- Scheduling (national classification system) (168)
- Safety monitoring and information (28)
- Advertising (25)
- COVID-19 (11)
- Manufacturing (11)
- Clinical trials (6)
- Medicinal cannabis hub (6)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
768 result(s) found, displaying 601 to 625
-
Meeting statementsACMD 32 meeting statement has been published
-
Meeting statementsAdvisory Committee on Medical Devices
-
Meeting statementsAdvisory Committee on Medical Devices (ACMD) meeting statement.
-
Meeting statementsMeeting 34 of the Advisory Committee on Medical Devices (ACMD).
-
Scheduling decisions (final)Final decisions and reasons for matters referred to ACCS#20, ACMS #21 (July 2017 meetings) and Joint ACCS-ACMS #15 and #16 (March and July 2017meetings).
-
Meeting statementsAdvisory Committee on Biologicals (ACB), Meeting 7 statement
-
Meeting statementsAdvisory Committee on Biologicals (ACB), Meeting 8 statement
-
Meeting statementsAdvisory Committee on Biologicals (ACB), Meeting 9 statement
-
Meeting statementsAdvisory Committee on Biologicals (ACB), Meeting 10 statement
-
Meeting statementsAustralian Influenza Vaccine Committee (AIVC) recommendations
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 3 October 2017
-
Meeting statementsAdvisory Committee on Complementary Medicines Meeting 17 meeting statement
-
Meeting statementsACMD 31 meeting statement has been published
-
Meeting statementsACM 1 meeting statement has been published
-
Corporate reportsTGA Stakeholder Survey 2016-17 - questions and answers
-
Scheduling decisions (final)Final decisions for medicines and chemicals referred to March 2017 scheduling meetings (ACMS #20, ACCS #19 and Joint ACMS-ACCS #15) and NCEs.
-
Corporate reportsSummary of generic and biosimilar prescription medicines registered in Australia in 2016
-
Scheduling decisions (final)New Chemical Entity (NCE) delegate's final decision and reasons for decision for brexpiprazole
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closed: 31 May 2017
-
Meeting statementsACMD meeting statement, Meeting 25, 26 February 2016
-
Meeting statementsACMD meeting statement, Meeting 26, 29 April 2016
-
Meeting statementsACMD meeting statement, Meeting 27, 24 June 2016
-
Meeting statementsACMD meeting statement, Meeting 28, 26 August 2016
-
Meeting statementsACMD meeting statement, Meeting 29, 21 October 2016
-
Meeting statementsACMD meeting statement, Meeting 30, 2 December 2016